The supporting information also contains four tables: Table S1 contains the chromatographic conditions used for the secondary and tertiary isocratic separations of each features of interest; Table S2 shows the NMR signal assignment of Feature A, tetrahydropentoxyline; Table S3 shows the NMR signal assignment of Feature B, indole-3-acetic-acid-O-alpha-glucuronide; Table S4 shows the NMR signal assignment of Feature D, pregnanediol-3-glucuronide.
shows an ES-MRMS with an isotopic fine structure confirmation of elemental composition (C 16 H 16 NO 8 ) of purified Feature B; Figure S11 shows evidence of the degradation of purified Feature B when stored in phosphate buffer; Figure S12 shows the 1 H-1 H COSY NMR spectrum of Feature B; Figure S13 shows the 1 H-13 C HMBC NMR spectrum of Feature B; Figure   S14 Negative MS/MS spectrum and statistical heterospectroscopy analysis of feature C; Figure S15 shows EIC chromatogram (ES-) comparing urine pool with analytical standard of pregnanediol-3-glucuronide; Figure S16 shows an ES-MRMS with an isotopic fine structure confirmation of elemental composition (C 27 H 43 O 8 ) of purified Feature C; Figure S17 shows the 1 H-1 H COSY NMR spectrum of Feature D; Figure S13 shows the 1 H-13 C HMBC NMR spectrum of Feature D;
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MATERIALS AND METHODS
Secondary and tertiary isocratic fractionation
To generate the library of isocratic chromatography conditions, four reversed-phase C18 chemistries were assessed (Waters X-Bridge BEH C18; Waters X-select CSH C18, Waters, Sunfire C18, Waters Atlantis T3 C18)). Columns of dimensions 4.6mm x 150mm,3µm were used in each case. Two solvent combinations were employed: the first consisted of water (0.1% formic acid) and acetonitrile (0.1% formic acid), whilst the second replaced acetonitrile with methanol as the organic modifier. Overall, eleven sets of reversed phase isocratic conditions were assessed using two solvent gradients (99% A, 95% A and then at 5% interval decreases to 50% A).
It should also be noted that an additional Waters X-Bridge BEH C8 column with selectivity similarities with the X-Bridge C18 was used in cases where the X-Bridge C18 required further bespoke modification.
Two HILIC phase chemistries were additionally assessed for the database (Waters X-Bridge HILIC;
Waters Atlantis HILIC). The column dimensions were 4.6mm x 150mm, 3µm in each case. For the HILIC database only one mobile phase combination was employed consisting of 20mM ammonium formate in water (A) and 0.1% formic acid in acetonitrile (B). Ten sets of HILIC isocratic conditions were assessed (5% A and then at 5% interval increases up to 50% A).
MRMS analysis
Magnetic resonance mass spectra (MRMS) were acquired with a Bruker solariX 2xR (Bruker Daltonics, Billerica, MA, US) using electrospray ionization (ES) and direct infusion with syringe pump. The fraction samples were diluted 1:9 in 50% acetonitrile + 0.1% formic acid for ES+. Fraction samples were diluted 1:9 in 50% acetonitrile ES-. Samples were measured with direct infusion using a flow of 2 µl/min. Mass spectra were acquired with a mass resolution of 1.350.000 at m/z 200 using quadrupolar detection. 64 single scans were added for the final mass spectrum. Spectra were externally mass calibrated with NaTFA cluster.
NMR analysis
A range of 2D NMR spectroscopy experiments including J-resolved, 1 H, 1 H-COSY, 1 H, 1 H-TOCSY, 2D 
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doublet (d); doublet of doublets (dd); triplet (t); doublet of triplets (dt)
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s); doublet (d); doublet of doublet of doublets (ddd); triplet (t); doublet of triplets (dt)
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singlet (s); doublet (d); triplet (t); multiplet (m); triplet of doublets (td); doublet of triplets (dt)
S-9 Figure S1 . Photographs and metabolite feature heatmaps of desalted urine (a) and non-desalted control urine (b)
after 10-fold pre-concentration. Significant salt precipitation is seen in the control concentrated urine. Heatmaps representing the distribution of the top 1000 features (ranked by MS intensity, x-axis) across the 120 collected fractions (y-axis) after 100 repeat fraction collections from 1 mL injections of urine. Table S2 .
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Labels match the chemical groups as labelled in Figure 2 . Figure S7 . Plots presenting two details of the 1 H-13 C HMBC spectrum a) 7-8 ppm, and b) 3.1-3.7 ppm regions with encircled key correlations corresponding to the structure and assignment of Feature A as presented in Table   S2 . Labels match the chemical groups as labelled in Figure 2 . 
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Figure S12. Plots showing two details of the 1 H-1 H COSY spectrum a) 6.8-8 ppm, and b) 3-5.5 ppm regions with encircled key correlations corresponding to the structure and assignment of Feature B as presented in Table S3 in the main text. Labels match the chemical groups as labelled in Figure 2 . Figure S13 . Plots presenting two details of the 1 H-13 C HMBC spectrum a) 7 -7.8 ppm, and b) 3.5-4.1 ppm regions with encircled key correlations corresponding to the structure and assignment of Feature B as presented in Table   S3 in the main text. Labels match the chemical groups as labelled in Figure 2 .
S-20 S-21 Table S4 . Labels match the chemical groups as labelled in Figure 2 . Figure S18 . Plots presenting two expansions (a) and (b) of the 1 H-13 C HMBC spectrum with encircled key correlations corresponding to the structure and assignment of Feature D as presented in Table S4 . Labels match the chemical groups as labelled in Figure 2 .
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